Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-09 | 92140 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2019-09-19 | 92157 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-17 | 92215 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-09-26 | 2020-08-21 | 94858 |
| TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99962 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-12-05 | 2020-01-30 | 100287 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-09 | 2020-03-26 | 102917 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-01-30 | 103566 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-01-24 | 2021-03-11 | 104339 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-01-24 | 2021-01-01 | 104344 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-02-13 | 2020-03-19 | 106015 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106913 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110779 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2020-04-10 | 2020-04-16 | 111816 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-04-10 | 2020-05-21 | 111835 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-04-10 | 2021-04-15 | 111862 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112382 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2020-05-21 | 2020-06-04 | 115553 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |